Today: 17 May 2026
XRP Price Today: Ripple’s $50 Billion Buyback Still Fails to Lift the Token
12 March 2026
1 min read

XRP Price Today: Ripple’s $50 Billion Buyback Still Fails to Lift the Token

NEW YORK, March 12, 2026, 13:57 EDT

XRP hovered close to $1.38 on Thursday, slipping around 1.4%. Bloomberg flagged Ripple’s new share buyback, pegging the company’s value at $50 billion, and Ripple announced plans for an Australian financial services license. The token barely budged—fresh headlines, but no spark for XRP’s sideways drift.

Crypto barely budged, with macro forces back in the driver’s seat. Oil lingered close to $100, the dollar held steady, and digital asset traders looked past Ripple’s expansion, focusing instead on the odds of U.S. rate cuts.

Bigger tokens echoed the trend. Bitcoin dipped 0.7% to $70,331. Ether barely moved, holding at $2,065. XRP tracked alongside the group, not reacting to any specific company news.

The U.S. consumer price index landed at 0.3% higher for February, up 2.4% year over year—figures that gave investors a brief breather on Wednesday. But attention snapped back to concerns over inflation, this time stoked by the Middle East oil shock.

Monica Guerra at Morgan Stanley Wealth Management said stubbornly high oil prices could “complicate” the Fed’s next steps. Goldman Sachs just shifted its rate-cut forecast to September, scrapping its earlier June prediction. Still, a Reuters poll showed most economists are holding onto bets for a June cut. Reuters

On March 11, Ripple announced plans to obtain an Australian Financial Services License by acquiring BC Payments Australia, opening the door for the company to manage settlement, compliance, currency conversion, and payouts itself. “Licensing is fundamental to Ripple’s strategy,” said Fiona Murray, Ripple’s Asia-Pacific managing director. The company highlighted APAC payments volume that nearly doubled in 2025. Ripple

Ripple is looking to repurchase as much as $750 million in shares from employees and investors, Bloomberg said, with the buyback running through April. That move would peg Ripple’s valuation at $50 billion—higher than the $40 billion figure it revealed after pulling in $500 million last November.

XRP hasn’t completely shaken off the fallout from the SEC lawsuit that kicked off in 2020. A federal judge in New York determined in 2023 that XRP sales through public exchanges didn’t qualify as securities. Still, it wasn’t until August 2025 that the saga wrapped for good, with both Ripple and the regulator abandoning their appeals. Ripple was left with a $125 million penalty and an injunction.

Right now, XRP is trading more in line with the big-name crypto tokens than reflecting Ripple’s private market value. On Thursday, the token moved between $1.37 and $1.41—nowhere close to its 52-week high of almost $3.66. The core risk is clear: if oil prices remain elevated and rate cuts get pushed even further out, XRP might just hover here or even slide lower with the rest of crypto.

Stock Market Today

  • Meta Platforms Stock Quote Price and Forecast
    May 16, 2026, 10:17 PM EDT. Meta Platforms, Inc. develops major social media applications including Facebook and Instagram through its Family of Apps segment, and invests in augmented and virtual reality via Reality Labs. Founded in 2004 by Mark Zuckerberg and co-founders, the Menlo Park-based company drives connectivity and business growth through technology. Meta's stock reflects its dual focus on social media dominance and emerging reality technologies, impacting market forecasts and investment outlooks.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Grab Holdings Stock Price Falls 3% as CEO Share Sale Filing Adds Pressure
Previous Story

Grab Holdings Stock Price Falls 3% as CEO Share Sale Filing Adds Pressure

Occidental Petroleum Stock in Focus as $100 Oil Pushes OXY to $59
Next Story

Occidental Petroleum Stock in Focus as $100 Oil Pushes OXY to $59

Go toTop